California Healthline Daily Edition

Summaries of health policy coverage from major news organizations

Sacramento Firm Nabs $5M for Stem Cell Harvesting

Sacramento-based SynGen announced that it received $5 million in funding from the San Francisco venture capital firm Bay City Capital to further develop its stem cell harvesting systems. SynGen will use the funding to develop, market and obtain regulatory approval for SynGen-1000, which harvests stem and progenitor cells for use in various treatments.

This is part of the California Healthline Daily Edition, a summary of health policy coverage from major news organizations. Sign up for an email subscription.